Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nexrutine in Prostate Cancer Patients Undergoing Surgery or Radiation
NCT01705652Phase 2Terminated
- Sponsor
- UT Health San Antonio
- Start
- Jul 2011
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of phellodendron amurense bark in prostate cancer (PCa), sponsored by UT Health San Antonio. Started Jul 2011; status: terminated.
02
Drugs
phellodendron amurense bark
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01705652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01705652.